Nina Hobi

Swisscom (Switzerland)

Papers

1

Total Citations

14

H-Index

1

About

Nina Hobi is a pioneering researcher in pulmonary bioengineering, with a primary focus on developing advanced in vitro models to study lung diseases and environmental exposures. Her work centers on creating next-generation "lung-on-chip" systems that replicate human respiratory physiology with unprecedented accuracy. Hobi’s major contribution lies in engineering a breathing lung-on-chip platform integrated with a smoke inhalation system, enabling real-time modeling of human lung responses to cigarette smoke exposure. This breakthrough addresses the limitations of animal models, which fail to capture human-specific lung physiology and smoke inhalation dynamics. Her most-cited paper (2025, 14 citations) introduces this system to study chronic obstructive pulmonary disease (COPD) and lung cancer progression, offering a transformative tool for toxicology and drug testing. Though early in citation accumulation, Hobi’s work is gaining rapid recognition for its potential to replace animal testing and accelerate therapeutic development. Her achievements include bridging microfluidic technology with pulmonary medicine, positioning her as a rising leader in organ-on-chip research. For students and researchers, Hobi exemplifies how innovative bioengineering can unravel complex lung pathologies and improve translational outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
A next-generation system for smoke inhalation integrated with a breathing lung-on-chip to model human lung responses to cigarette exposure
14 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Swisscom (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago